| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 09/16/2004 | WO2003095398A3 Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same |
| 09/16/2004 | WO2003052048A3 Nucleic acid-associated proteins |
| 09/16/2004 | WO2003045318A3 Manipulation of cytokine levels using cd83 gene products |
| 09/16/2004 | US20040181069 modulators of the monoamine receptors, in particular the serotonin, dopamine and norepinephrine receptors, and the biogenic amine transporters for serotonin, dopamine and norepinephrine; |
| 09/16/2004 | US20040181059 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 09/16/2004 | US20040181047 33 human secreted proteins |
| 09/16/2004 | US20040180944 Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterase (cGMP-PDE5) for the treatment of sexual dysfunction |
| 09/16/2004 | US20040180941 3-(1-[3-(1,3-Benzothiazol-6-yl)propylcarbamoyl]cycloalkyl)propanoic acid derivatives as NEP inhibitors |
| 09/16/2004 | US20040180925 such as (S)-1-[2-(2-Pyrazinylamino)ethylamino]acetyl-2-pyrrolidinecarbonitrile dimethanesulfonate |
| 09/16/2004 | US20040180923 obesity, diabetes, male sexual dysfunction, and female sexual dysfunction |
| 09/16/2004 | US20040180907 for use in fertility regulating therapies |
| 09/16/2004 | US20040180887 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 09/16/2004 | US20040180879 Novel method of treating vasomotor symptoms |
| 09/16/2004 | US20040180878 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use |
| 09/16/2004 | US20040180877 Nicotinic acetylcholine receptor cholinergic ligands, monoamine receptor and transporter modulators; such as 1-(2-Benzo[b]thiophenyl-1,1-dioxide)-imidazolidine |
| 09/16/2004 | US20040180876 Selective beta 2-adrenoreceptor agonists; rapid onset of action, long duration; such as 3-(4-{[6-{(-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)phenyl]ethyl}amino)hexyl]oxy}butyl)benzenesulfonamide; synthesis |
| 09/16/2004 | US20040180873 Thieno{2,3-d}pyrimidines with combined lh and fsh agonistic activity |
| 09/16/2004 | US20040180867 Daily administration of 17 beta-estradiol and every other day including norgestimate |
| 09/16/2004 | US20040180856 Aqueous solution including partially methylated cyclodextrin |
| 09/16/2004 | US20040180832 Sustained peptide-release formulation |
| 09/16/2004 | US20040180830 Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder |
| 09/16/2004 | US20040180407 Novel G protein coupled receptor protein, DNA and its ligand |
| 09/16/2004 | CA2768008A1 Clostridial neurotoxins for treating uterine disorders |
| 09/15/2004 | EP1457490A1 5-membered N-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 09/15/2004 | EP1457208A1 Methods and pharmaceutical compositions for reliable achievement of acceptable serum testosterone levels |
| 09/15/2004 | EP1456365A2 Protein modification and maintenance molecules |
| 09/15/2004 | EP1456219A1 Crystalline form of a ribofuranosyluronamide derivative; a human adenosine A2a receptor agonist |
| 09/15/2004 | EP1456212A1 6-aminomorphinane derivatives, method for the production and use thereof |
| 09/15/2004 | EP1456203A1 Ethylene diamine derivatives and their use as orexin-receptor antagonists |
| 09/15/2004 | EP1456199A1 Salt forms of e-2-methoxy-n-(3-(4-(3-methyl-pyridin-3-yloxy)-phenylamino)-quinazolin-6-yl)-allyl)-acetamide, its preparation and its use against cancer |
| 09/15/2004 | EP1456192A1 Deuterated substituted dihydrofuranones and medicaments containing these compounds |
| 09/15/2004 | EP1456178A1 7-sulfonyl-3-benzazepine derivatives as modulators of the dopamine receptor and their use for the treatment of cns disorders |
| 09/15/2004 | EP1455847A1 Feminine care products for the delivery of therapeutic substances |
| 09/15/2004 | EP1455791A1 Method for administering birb 796 bs |
| 09/15/2004 | EP1455789A2 Imiquimod therapies |
| 09/15/2004 | EP1455785A1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same |
| 09/15/2004 | EP1455781A1 Use of anastrozole for the treatment of post-menopausal women having early breast cancer |
| 09/15/2004 | EP1455734A1 Compositions comprising phenyl-glycine derivatives |
| 09/15/2004 | EP1455697A1 Vaginal delivery of drugs |
| 09/15/2004 | EP1294729B1 2-aminoalkyl-thieno[2,3-d]pyrimidines |
| 09/15/2004 | EP1173440B1 Tetracyclic azepinoindole compounds as 5-ht receptor ligands |
| 09/15/2004 | EP1173210B1 Contraceptive compositions containing antiprogestinic and progestinic |
| 09/15/2004 | EP1133487B1 Antioxidants |
| 09/15/2004 | EP1133467B1 Ion channel modulating agents |
| 09/15/2004 | EP1054669B9 Use of thiadiazolo[4,3-a]pyridine derivatives |
| 09/15/2004 | EP1015010A4 Prevention of pregnancy miscarriages |
| 09/15/2004 | EP0680327B1 Therapeutic uses and delivery systems of dehydroepiandrosterone |
| 09/15/2004 | EP0656786B1 Use of isoflavone phyto-oestrogen extracts of soy or clover |
| 09/15/2004 | CN1529697A Tricyclic compounds useful as angiotensin II agonists |
| 09/15/2004 | CN1529601A 四氢喹啉衍生物 Tetrahydroquinoline derivative |
| 09/15/2004 | CN1528882A Amauoderma rude liquid fermenting method and product obtained thereby |
| 09/15/2004 | CN1528792A Method for extracting red blood cell membrane extract and its use |
| 09/15/2004 | CN1528753A Morpholol with medicinal activity |
| 09/15/2004 | CN1528441A Paster for regulating menstruation and relieving pain |
| 09/15/2004 | CN1528422A Motherwort soft capsule and preparing method thereof |
| 09/15/2004 | CN1528411A External plaster for treating mammary gland proliferation, mammary lobe proliferation and mammary cystic proliferation |
| 09/15/2004 | CN1528396A Medicine for treating oligospermia and preparing process thereof |
| 09/15/2004 | CN1528374A Complex rhizoma paridis tincture and preparing method thereof |
| 09/15/2004 | CN1528365A Capsule for activating mammary gland meridians |
| 09/15/2004 | CN1528356A Use of plant spearmint for preparing medicines for treating women's inflammation and hemorrhagic diseases |
| 09/15/2004 | CN1528341A Povidone-iodine foamable composition |
| 09/15/2004 | CN1528314A Tibolone drop pill and preparing method thereof |
| 09/15/2004 | CN1528305A Radix sen rhizoma fibraureae extract drop pill and preparing method thereof |
| 09/15/2004 | CN1528286A Soybean aglycone drop pill and preparing method thereof |
| 09/15/2004 | CN1166680C Novel androgens |
| 09/15/2004 | CN1166678C Purine derivatives |
| 09/15/2004 | CN1166412C Wet tissue with disinfecting medicine and sterilizing powder |
| 09/15/2004 | CN1166377C Medicine for treating woman's acyesis |
| 09/15/2004 | CN1166361C Use of CGRP antagonists and CGRP release inhibitors for controlling menopausal hot flashes |
| 09/14/2004 | US6790979 Use as antitumor agents, particularly for the treatment of cancers such as colon, skin and prostate cancer and to induce androgen receptor antagonist activity in subject with androgen-related affliction |
| 09/14/2004 | US6790953 Ether compounds |
| 09/14/2004 | US6790941 Zinc finger protein derivatives and methods therefor |
| 09/14/2004 | US6790860 Pyrrolidine derivatives |
| 09/14/2004 | US6790853 Contraception method using competitive progesterone antagonists and novel compounds useful therein |
| 09/14/2004 | US6790628 Screening granulocyte colony stimulating factor(g-csf) poly-peptide analogs to use as g-csf replacements or antagonists; sensitizing cells to chemo/radiotherapy; treating hemato-poietic, neurological or reproduction related conditions |
| 09/14/2004 | US6790443 Administering to the subject a therapeutically effective amount of an agent which inhibits binding of advanced glycation endproducts to any receptor for advanced glycation endproducts |
| 09/10/2004 | WO2004076476A1 Glycopeptide and use thereof as proteoglycan initiator |
| 09/10/2004 | WO2004076407A2 Pyrrolidine derivatives as oxytocin antagonists |
| 09/10/2004 | WO2004075890A1 Medicinal composition containing stabilized imidazole derivative and method of stabilizing imidazole derivative |
| 09/10/2004 | WO2004075823A2 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament |
| 09/10/2004 | WO2004022128A3 Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols |
| 09/10/2004 | WO2004017920B1 Novel biphenyl and biphenyl-like cannabinoids |
| 09/10/2004 | WO2004014352A3 Methods for treating carbonic anhydrase mediated disorders |
| 09/10/2004 | WO2003090671A3 Chromium compositions and methods for using the same for inhibiting drug-induced insulin resistance |
| 09/10/2004 | WO2003003979A3 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions |
| 09/10/2004 | CA2516660A1 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament |
| 09/09/2004 | US20040176456 Method of treatment for sexual dysfunction |
| 09/09/2004 | US20040176428 treatment of Type 2 diabetes mellitus, obesity and lipid disorders; coadministration with HMG CoA reductase inhibitors |
| 09/09/2004 | US20040176417 Substituted 2-thio-3, 5-dicyano-4-phenyl-6-aminopyridines and their use as adenosine receptor-selective ligands |
| 09/09/2004 | US20040176400 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf) |
| 09/09/2004 | US20040176379 agonist effect from one or more of a somatostatin subtype receptor; diabetes mellitus, hyperlipidemia, insulin insensitivity, Syndrome X; inhibiting the proliferation of helicobacter pylori |
| 09/09/2004 | US20040176371 1,6-Dihydropyrazolo[4,3-d]pyridine-7-thione derivatives; phosphodiesterase inhibitors; side effect reduction; chlorosulfonation; thionation |
| 09/09/2004 | US20040176365 1,8-Naphthyridin-2(1H)-one derivatives; antiasthmatic, antihistamine, and bronchodilator agents; nontoxic, side effect reduction |
| 09/09/2004 | US20040176324 Derivatives of 4,7-ethanothiopyrano[3,4-c]pyrrole-1,3-(2H)-dione, 4,7-epoxy-1H-isoindole-1,3(2H)-dione, and/or 4,7-ethano-1H-pyrrolo[3,4-c]pyridine-1,3(2H)-dione derivatives; autoimmune diseases; anticarcinogenic agents |
| 09/09/2004 | US20040176310 Use of extracts and preparations from iris plants and tectorigenin as medicaments |
| 09/09/2004 | US20040176284 1,2-Dithio-5,8,11,14,17-pentaazocycloeicosane derivatives |
| 09/09/2004 | US20040175419 controlling crystallization parameters of active ingredient to achieve increased compactability; compacting the active ingredient into a tablet |
| 09/09/2004 | US20040175378 Monoclonal antibody 3G4, or an antigen-binding region or immunoconjugate thereof, produced by hybridoma ATCC PTA 4545; binds to phosphatidyl serine |
| 09/09/2004 | DE10107663B4 Testosteronhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung Testosterone-containing transdermal therapeutic system, process for its preparation and its use |
| 09/08/2004 | EP1453916A2 Novel combination containing a poloxamer and chondroitin sulphuric acid and/or a glycoprotein and use thereof |